TRUE Private Wealth Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 1667074 Salem, OR

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$243,204

-$27,452 QoQ

Shares Held

1,925

-0.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,802

of 2,266 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. GILD ranks #8 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,739	$8,082,959
2	JNJ	Johnson & Johnson	26,804	$6,807,411
3	ABBV	AbbVie Inc.	24,787	$6,237,400
4	MRK	Merck & Co., Inc.	27,029	$3,473,226
5	PFE	Pfizer Inc	66,968	$1,612,589
6	BMY	Bristol Myers Squibb Co	9,727	$560,469
7	AMGN	Amgen Inc	808	$292,592
8	GILD	Gilead Sciences, Inc. This page	1,925	$243,204

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$243,204	1,925	-0.9%	Shares	Sole	2026-07-23
2026-03-31	$270,656	1,942	+0.4%	Shares	Sole	2026-05-15
2025-12-31	$237,501	1,935	+3.3%	Shares	Sole	2026-02-13
2025-09-30	$208,014	1,874	0.0%	Shares	Sole	2025-11-14
2025-06-30	$207,770	1,874	-7.9%	Shares	Sole	2025-08-11
2025-03-31	$228,021	2,035	-20.9%	Shares	Sole	2025-05-15
2023-12-31	$208,357	2,572	+3.7%	Shares	Sole	2024-01-30
2023-03-31	$205,765	2,480	0.0%	Shares	Sole	2023-05-11
2022-12-31	$212,908	2,480	-21.1%	Shares	Sole	2023-02-14
2021-12-31	$228,213	3,143	-0.4%	Shares	Sole	2022-02-11
2021-09-30	$220,516	3,157	-91.1%	Shares	Sole	2021-11-05
2020-12-31	$2,072,949	35,581	-5.1%	Shares	Sole	2021-01-11
2020-09-30	$2,369,625	37,500	+17.8%	Shares	Sole	2020-10-09
2020-06-30	$2,448,384	31,822	+1.6%	Shares	Sole	2020-07-07
2020-03-31	$2,341,258	31,317	—	Shares	Sole	2020-04-20
No filing history on record for this holder in this stock.